JACQUELINE CZWOJDAK: Open Payments
NPI 1285186320 · CORNING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 81 payments from 13 companies in 2025. Trend: 2023 $1,499 · 2024 $1,274 · 2025 $1,642
Food & beverage: $1,608Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $460 |
| GlaxoSmithKline, LLC. | 20 | $251 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $247 |
| Amgen Inc. | 11 | $182 |
| GENZYME CORPORATION | 7 | $133 |
| PFIZER INC. | 5 | $101 |
| CSL Behring | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Grifols USA, LLC | 1 | $35 |
| Genentech USA, Inc. | 1 | $23 |
Products named: TEZSPIRE, NUCALA, FASENRA, CUVITRU, BREZTRI, DUPIXENT, HYQVIA, Haegarda.
Industry payments across NY — which companies pay providers there.
